Sen. Bernie Sanders criticized Novo Nordisk, claiming CEOs of generic pharmaceutical companies can produce and sell Ozempic for less than $100 a month. He made the remark during an expert roundtable event on Capitol Hill ahead of Novo Nordisk CEO Lars Fruergaard Jorgensen’s testimony before the Senate Health, Education, Labor and Pensions committee.
Full Article
Loading PerspectiveSplit analysis...
